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Introduction
Cystadenomas of the liver are rare tumours that can be dif-
ficult to diagnose and treat. They generally predominate in
females, with a mean age of 40–45 years [1,2]. These
tumours can be classified according to the presence or
absence of mesenchymal stroma [1]. All reported cases of
cystadenoma with mesenchymal stroma (CMS) have
occurred in females. Since these lesions are neoplastic, the
treatment of cystadenomas of the liver entails complete sur-
gical extirpation; partial excision guarantees local recur-
rence [1,2]. Removal may be accomplished by hepatic
resection or simple enucleation. Large tumours up to 25 cm
in diameter have been described replacing an entire lobe,
and surgical excision of such lesions is technically chal-
lenging [1]. We report a rare case of cystadenoma without
mesenchymal stroma in a female patient.
Case report
This 19-year-old, previously healthy, Caucasian woman
presented in March 1999 with a 2-week history of constant,
progressive, right upper quadrant abdominal pain radiating
to her back. The pain had become severe enough to inter-
fere with sleep, and she required narcotic analgesics. There
was no prior history of liver disease. She had no history of
fever or chills, travel or contact with animals. Four months
earlier, she had been started on cyproterone acetate-ethinyl
oestradiol (Diane-35), a hormonal treatment for acne. She
consulted her physician after noticing a fullness in the
upper abdomen because the product Monograph of Diane-
35 warned that this may indicate a ‘possible tumour of the
liver’. Physical examination revealed massive hepatomegaly
but no stigmata of chronic liver disease. Laboratory tests
revealed a normal complete blood count and abnormal
liver enzyme tests; ALT 57 IU/L (normal 7–56), GGT
177 IU/L (normal 7–32), ALP 407 IU/L (normal 39–117),
bilirubin 29 mol/L (normal 0–20), albumin 27 g/L (nor-
mal 33–50). An abdominal ultrasound scan demonstrated a
large cystic lesion of the liver and questioned the presence
of ‘daughter’ cysts with internal debris. A computed tomog-
raphy scan confirmed a 20-cm multiloculated cystic mass of
the central part of the liver (Figure 1a and b).
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Liver cystadenomas are relatively rare tumours that can
be difficult to diagnose; treatment entails complete surgical
extirpation either by either anatomical resection or
enucleation.
Case outline
A 19-year-old woman presented with acute onset of
abdominal pain and was found to have a multilocular giant
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CA 19-9 tumour markers were elevated in this cyst fluid:
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mal stroma, and tumour oestrogen and progesterone
receptors were negative.
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trates the possible relationship between hormonal therapy
and tumour growth.
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As the ultrasound was suspicious for hydatid cyst dis-
ease, the patient was started on albendazole. After 5 days,
her abdominal pain and distension worsened and percuta-
neous drainage of the largest cyst was performed for relief of
symptoms. A total of 2550 ml of brown fluid was aspirated.
Analysis of the fluid revealed no parasitic cysts, ova or
echinococcal scolices. Echinococcal serology was negative.
Bacterial and fungal cultures were also negative. Tumour
markers from the fluid were elevated with a CEA level of
96 g/L (normal 0–5, AXSYM immunoassay analyser) and
CA 19-9 of 37 550 kU/L (normal ,35, BIOMIRA
TRUQUANT GI radioimmunoassay). Serum levels of
CEA and CA 19-9 were normal.
At laparotomy a large central 20-cm multilocular cyst
was found within the right anterior sector of the liver the
cyst walls were of heterogeneous thickness. The cyst rested
between the right and middle hepatic veins, which were
compressed against its lateral walls. Inferiorly, the hilar
plate was associated with the cyst, and posteriorly the pos-
terior sector vasculobiliary sheath was compressed against
its wall. Complete enucleation of the cyst was accom-
plished, and there were no postoperative complications. No
perioperative blood transfusions were required. The final
pathological diagnosis was a cystadenoma without mes-
enchymal stroma. Immunohistochemical staining revealed
an absence of oestrogen and progesterone receptors in the
lesion. Follow-up CT scan at 6 weeks (Figure 2) showed
complete resolution, and 1 year later there is no evidence
of recurrence.
Discussion
Cystadenomas of the liver are characterised by multilocular
cysts with an epithelial lining composed of columnar to
cuboidal cells capable of mucin production. A separate
class of cystadenomas has associated CMS that is inter-
posed between the epithelial lining and an outer layer of
collagenised connective tissue [1]. The mesenchymal stro-
ma has a distinct appearance that resembles primitive mes-
enchyme; cell differentiation varies from smooth muscle or
fibroblasts, to adipocytes or capillaries. CMS (Edmonson’s
tumour) occur exclusively in women, while cystadenomas
without mesenchymal stroma predominate in men [3,4].
CMS appear to arise from primitive embryonal cells [4],
and the presence of mesenchymal stroma may be a conse-
quence of the female hormonal milieu as previous studies
have demonstrated progesterone receptors in mesenchymal
stroma [5]. This finding would explain the female predilec-
tion for these tumours. CMS may give rise to both cystade-
nocarcinomas and sarcomas, including smooth muscle
tumours [4,6].
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Figure 1a,b. Preoperative CT scan showing large cystadenoma located cen-
trally in the right anterior sector of the liver.
Figure 2. Postoperative CT scan showing collapse of the cyst cavity following
enucleation.
a
b
The occurrence of cystadenomas without mesenchymal
stroma in a female is extremely rare, having been reported
in only three previous patients [6,7]. To confirm that a cys-
tadenoma in a female does not contain mesenchymal 
stroma, multiple sections must be examined histologically as
the mesenchymal stroma may be missed [1]. The presence
of elevated tumour markers in cyst fluid of a cystadenoma
without mesenchymal stroma has not previously been
described [8–12].
The initiation of hormonal therapy in our patient
4 months before the development of a symptomatic liver
mass suggests that oestrogens may accelerate the growth of
cystadenomas. The relatively short history of progressively
increasing abdominal pain to the point where narcotic
analgesics and eventually percutaneus decompression were
required is consistent with rapid expansion of this lesion.
Three earlier studies have documented increased levels of
oestrogen and progesterone receptors in cystadenomas with
mesenchymal stroma [13–15]. Immunoreactivity to oestro-
gen receptors was demonstrated within the mesenchymal
stroma [15]. This finding raises the possibility that there
were some areas of the tumour not seen on sectioning that
contained mesenchymal stroma [1] or that the biliary
endothelium of the tumour responded to the oestrogen. It
would seem prudent for any patient with a suspected cys-
tadenoma to avoid oestrogen-containing medications.
Cystadenomas may present in a variety of ways. Small
asymptomatic cysts may be detected incidentally on imag-
ing studies or during laparotomy. Large lesions may cause
pain, anorexia, nausea, vomiting, a palpable mass and caval
or biliary obstruction secondary to a mass effect [16,17].
Our patient presented predominately with pain, which was
probably due to stretching of the overlying Glissonian cap-
sule.
The differential diagnosis of cystic lesions of the liver
includes parasitic, simple and neoplastic cysts. Parasitic
cysts can generally be ruled out by history and serological
tests. The differentiation between simple cysts and cystade-
nomas without mesenchymal stroma can be more difficult.
However, in the present case the cyst was multilocular,
which is not typical of simple cysts. The other important
differentiating feature is the presence of the elevated
tumour markers (CEA and CA19-9) in the cyst fluid. Prior
studies have demonstrated that these tumour markers are
not elevated in simple or hydatid cysts [8,9,18]. However,
several workers have shown that they may be elevated in
patients with cystadenomas and give an indication of their
biliary origin [8–12]. It is important to use all information
when elucidating the aetiology of a liver cyst including his-
tory, imaging studies, histology and tumour markers so as to
reach the correct diagnosis. The histology, multilocular
appearance and elevated tumour markers confirmed the
diagnosis of cystadenoma without mesenchymal stroma in
our patient.
The treatment of cystadenomas is always complete
removal either by resection or enucleation to avoid local
recurrence or the risk of malignant transformation. Smaller
lesions located within the substance of the liver may be
removed by segmental resection. Enucleation may be treat-
ment of choice for superficially located lesions or large cen-
tral lesions that abut the major vascular structures of the
liver. There is often a well-defined plane between the
lesion and the surrounding liver parenchyma that is rela-
tively avascular; this plane can be used for complete enu-
cleation with minimal blood loss [16,19], as in our patient.
One must always be careful that the lesion in question is
not a cystadenocarcinoma, so solid areas in the cyst wall
should be biopsied if enucleation is planned.
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